Abstract:The high performance and increased tumor-targeting accumulation of magnetic nanocrystals (MNCs) are the most important considerations in cancer targeted magnetic hyperthermia (TMH). To achieve these goals, our study was firstly done using well-established fluorescence/magnetic Mn-Zn ferrite MNCs (core size: 14 nm) as multi-modal imaging contrast agents and highly-efficient "heat generators", which were coated with a biocompatible PEG-phospholipid (DSPE-PEG2000) and further modified by a cyclic tripeptide of arginine-glycine-aspartic acid (RGD). By using a mouse model bearing breast carcinoma (4T1), we then systematically compared PEGylated MNCs (MNCs@PEG)- and RGD-PEGylated MNCs (MNCs@RGD)-mediated tumor targeting abilities by intravenous administration. The MNCs@PEG-based passive targeting could successfully accumulate at the tumor due to the enhanced permeability and retention (EPR) effects, but the non-targeted localization might make the MNCs@PEG "leaking" from larger pores of tumor fenestrated vascular networks. Our designed MNCs@RGD, simultaneously functionalized with PEG and RGD ligands, might promote a synergistic effect including efficient tumor vasculature active targeting and EPR-mediated passive targeting, improving total MNC concentration and retention time in tumor tissues. By combining fluorescence/magnetic resonance (MR)/thermal multi-modal imaging-guided diagnostics and continuous TMH treatment under an alternating current magnetic field (ACMF, 2.58 kA m(-1), 390 kHz), the tumor surface could be heated to approximately 43-44 °C based on the MNC-mediated repeated injections. Sufficient temperature elevation induced the apoptosis of tumor cells, and inhibited the tumor angiogenesis. Compared with MNCs@PEG, the active MNCs@RGD-based tumor targeting MR image was significantly more efficient due to both the higher and long-lasting tumor accumulation, but its antitumor efficacy was not obviously improved in the TMH treatments. To achieve a singularly promising tumor TMH therapy, a greatly increased MNC content in tumor was needed. This insight indicated that not only the tumor vasculature targeting, but also the active tumor cells targeting of MNCs should receive considerable attention in future clinical TMH therapy application.

Anti-tumor effect of mitomycin-loaded magnetic nanospheres

In vitro investigation on the magnetic nanothermo-chemotherapy for cancer comprehensive treatment

Magnetic and Ph Dual-Responsive Nanoparticles for Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy

Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π–π Stacking and Its Therapeutic Application in Bladder Cancer

Enhanced tumor penetration for efficient chemotherapy by a magnetothermally sensitive micelle combined with magnetic targeting and magnetic hyperthermia

Magnetically triggered drug release from nanoparticles and its applications in anti-tumor treatment

AMF Responsive DOX-loaded Magnetic Microspheres: Transmembrane Drug Release Mechanism and Multimodality Postsurgical Treatment of Breast Cancer.

In Vitro Investigation on the Magnetic Thermochemotherapy Mediated by Magnetic Nanoparticles Combined with Methotrexate for Breast Cancer Treatment.

Magnetic Nanoliposomes As in Situ Microbubble Bombers for Multimodality Image-Guided Cancer Theranostics.

A Novel Magnetic Nanoparticle Hyperthermia Combined with Acmf-Dependant Drug Release by Damms Injection in Vx-2 Liver Tumors

Effects of ferromagnetic protein MMC-bearing microspheres on human liver cancer model in nude mice

Multi-modal Mn-Zn Ferrite Nanocrystals for Magnetically-Induced Cancer Targeted Hyperthermia: a Comparison of Passive and Active Targeting Effects.

Mangiferin Loaded Magnetic PCEC Microspheres: Preparation, Characterization and Antitumor Activity Studies in Vitro.

Time-Delayed Anticancer Effect of an Extremely Low Frequency Alternating Magnetic Field and Multimodal Protein–Tannin–Mitoxantrone Carriers with Brillouin Microspectroscopy Visualization In Vitro

Anti-tumor Effect in Vitro of ~(188)re Labeled Herceptin-coated Magnetite Nanoparticles

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Fabrication, Characterization and In-Vitro Cytotoxicity of Magnetic Nanocomposite Polymeric Film for Multi-Functional Medical Application

Magnetically Triggered Drug Release from Biocompatible Microcapsules for Potential Cancer Therapeutics

Magnetic Field Activated Drug Release System Based on Magnetic PLGA Microspheres for Chemo-Thermal Therapy.

Doxorubicin-conjugated Mesoporous Magnetic Colloidal Nanocrystal Clusters Stabilized by Polysaccharide As a Smart Anticancer Drug Vehicle.

Magnetic Targeting and Ultrasound Activation of Liposome-Microbubble Conjugate for Enhanced Delivery of Anti-Cancer Therapies.